JP2018150298A5 - - Google Patents

Download PDF

Info

Publication number
JP2018150298A5
JP2018150298A5 JP2018044050A JP2018044050A JP2018150298A5 JP 2018150298 A5 JP2018150298 A5 JP 2018150298A5 JP 2018044050 A JP2018044050 A JP 2018044050A JP 2018044050 A JP2018044050 A JP 2018044050A JP 2018150298 A5 JP2018150298 A5 JP 2018150298A5
Authority
JP
Japan
Prior art keywords
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018044050A
Other languages
English (en)
Other versions
JP2018150298A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018150298A publication Critical patent/JP2018150298A/ja
Publication of JP2018150298A5 publication Critical patent/JP2018150298A5/ja
Pending legal-status Critical Current

Links

Claims (1)

  1. 式:


    6、
    22、
    28、
    IV、
    11、
    13、
    15、
    16、
    26、
    27、
    30、
    31、
    32、
    34、
    36、
    37、
    43、または
    44
    を有する化合物。
JP2018044050A 2013-03-13 2018-03-12 ベンゾオキサゼピン化合物の作製方法 Pending JP2018150298A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361779619P 2013-03-13 2013-03-13
US61/779,619 2013-03-13

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015562108A Division JP6363120B2 (ja) 2013-03-13 2014-03-12 ベンゾオキサゼピン化合物の作製方法

Related Child Applications (3)

Application Number Title Priority Date Filing Date
JP2018153231A Division JP6663459B2 (ja) 2013-03-13 2018-08-16 ベンゾオキサゼピン化合物の作製方法
JP2018219226A Division JP2019089762A (ja) 2013-03-13 2018-11-22 ベンゾオキサゼピン化合物の作製方法
JP2020032846A Division JP2020114814A (ja) 2013-03-13 2020-02-28 ベンゾオキサゼピン化合物の作製方法

Publications (2)

Publication Number Publication Date
JP2018150298A JP2018150298A (ja) 2018-09-27
JP2018150298A5 true JP2018150298A5 (ja) 2019-01-31

Family

ID=50241450

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2015562108A Active JP6363120B2 (ja) 2013-03-13 2014-03-12 ベンゾオキサゼピン化合物の作製方法
JP2017135083A Active JP6442005B2 (ja) 2013-03-13 2017-07-10 ベンゾオキサゼピン化合物の作製方法
JP2018044050A Pending JP2018150298A (ja) 2013-03-13 2018-03-12 ベンゾオキサゼピン化合物の作製方法
JP2018153231A Active JP6663459B2 (ja) 2013-03-13 2018-08-16 ベンゾオキサゼピン化合物の作製方法
JP2018219226A Pending JP2019089762A (ja) 2013-03-13 2018-11-22 ベンゾオキサゼピン化合物の作製方法
JP2020032846A Pending JP2020114814A (ja) 2013-03-13 2020-02-28 ベンゾオキサゼピン化合物の作製方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2015562108A Active JP6363120B2 (ja) 2013-03-13 2014-03-12 ベンゾオキサゼピン化合物の作製方法
JP2017135083A Active JP6442005B2 (ja) 2013-03-13 2017-07-10 ベンゾオキサゼピン化合物の作製方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2018153231A Active JP6663459B2 (ja) 2013-03-13 2018-08-16 ベンゾオキサゼピン化合物の作製方法
JP2018219226A Pending JP2019089762A (ja) 2013-03-13 2018-11-22 ベンゾオキサゼピン化合物の作製方法
JP2020032846A Pending JP2020114814A (ja) 2013-03-13 2020-02-28 ベンゾオキサゼピン化合物の作製方法

Country Status (16)

Country Link
US (1) US9303043B2 (ja)
EP (3) EP3404032A3 (ja)
JP (6) JP6363120B2 (ja)
KR (3) KR101821468B1 (ja)
CN (2) CN108929333A (ja)
AR (1) AR095365A1 (ja)
AU (3) AU2014230812B2 (ja)
BR (1) BR112015020716A2 (ja)
CA (6) CA2897618A1 (ja)
HK (1) HK1215433A1 (ja)
IL (1) IL240793A0 (ja)
MX (1) MX2015011438A (ja)
NZ (1) NZ711192A (ja)
RU (2) RU2018109979A (ja)
SG (2) SG10201706760YA (ja)
WO (1) WO2014140073A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109293674A (zh) 2013-12-16 2019-02-01 豪夫迈·罗氏有限公司 Gdc-0032的多晶型物、其制备方法和药物用途
NZ736222A (en) * 2015-07-02 2024-05-31 F Hoffmann La Roche Ag Benzoxazepin oxazolidinone compounds and methods of use
WO2017001658A1 (en) 2015-07-02 2017-01-05 F. Hoffmann-La Roche Ag Benzoxazepin oxazolidinone compounds and methods of use
CN105906635A (zh) * 2016-06-08 2016-08-31 上海大学 全氟烷基苯并氮杂*并喹喔啉衍生物及其合成方法
WO2018021508A1 (ja) 2016-07-29 2018-02-01 日本たばこ産業株式会社 ピラゾール-アミド化合物の製造方法
TW201825465A (zh) 2016-09-23 2018-07-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201813963A (zh) 2016-09-23 2018-04-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201815787A (zh) 2016-09-23 2018-05-01 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
MX2019006958A (es) 2016-12-15 2019-08-01 Hoffmann La Roche Proceso para la preparacion de (s)-2-((2-((s)-4-(difluorometil)-2- oxooxazolidin-3-il)-5,6-dihidrobenzo[f]imidazo[1,2-d] [1,4]oxazepin-9-il)amino)propanamida.
CN108752237A (zh) * 2018-07-05 2018-11-06 四川青木制药有限公司 一种对氨基苯甲脒盐酸盐的新制备方法
WO2020130125A1 (ja) 2018-12-21 2020-06-25 第一三共株式会社 抗体-薬物コンジュゲートとキナーゼ阻害剤の組み合わせ

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846824A (en) 1994-02-07 1998-12-08 Ludwig Institute For Cancer Research Polypeptides having kinase activity, their preparation and use
GB9208135D0 (en) 1992-04-13 1992-05-27 Ludwig Inst Cancer Res Polypeptides having kinase activity,their preparation and use
US6274327B1 (en) 1992-04-13 2001-08-14 Ludwig Institute For Cancer Research Polypeptides having kinase activity, their preparation and use
AU1228100A (en) * 1998-10-23 2000-05-15 Dow Agrosciences Llc 3-(substituted phenyl)-5-(substituted cyclopropyl)-1,2,4-triazole compounds
KR20040024564A (ko) 2001-07-12 2004-03-20 아베시아 리미티드 마이크로캡슐화된 촉매, 이의 제조 방법 및 이의 사용 방법
MXPA04002931A (es) * 2001-10-12 2005-04-11 Bayer Pharmaceuticals Corp Heterociclos que contienen nitrogeno de 5 miembros sustituidos con fenilo para el tratamiento de la obesidad.
WO2007056170A2 (en) 2005-11-02 2007-05-18 Bayer Healthcare Ag Pyrrolo[2,1-f] [1,2,4] triazin-4-ylamines igf-1r kinase inhibitors for the treatment of cancer and other hyperproliferative diseases
ES2393132T3 (es) 2006-10-23 2012-12-18 Sgx Pharmaceuticals, Inc. Moduoladores de proteína quinasa de triazolopiridazina
EP2084162B1 (en) * 2006-10-23 2012-09-12 SGX Pharmaceuticals, Inc. Bicyclic triazoles as protein kinase modulators
JP2010516680A (ja) * 2007-01-19 2010-05-20 エックスカバリー,インコーポレイテッド キナーゼ阻害薬化合物
ES2439705T3 (es) * 2007-10-25 2014-01-24 Genentech, Inc. Proceso para la preparación de compuestos de tienopirimidina
CN102015693B (zh) * 2008-02-21 2014-10-29 默沙东公司 作为erk抑制剂的化合物
ES2480994T3 (es) 2008-03-31 2014-07-29 Genentech, Inc. Compuestos de tipo benzopirano y benzoxepina inhibidores de PI3K y métodos de uso
GB0810902D0 (en) 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
WO2011036280A1 (en) * 2009-09-28 2011-03-31 F. Hoffmann-La Roche Ag Benzoxazepin pi3k inhibitor compounds and methods of use
UA108863C2 (ru) 2009-09-28 2015-06-25 Ф. Хоффманн-Ля Рош Аг Бензоксепиновые ингибиторы pi3 и их применение
AU2010313469A1 (en) * 2009-10-29 2012-06-07 Merck Sharp & Dohme Corp. Bridged Bicyclic Piperidine Derivatives and methods of use thereof
CN102558167A (zh) * 2010-12-29 2012-07-11 中国医学科学院药物研究所 Gk和ppar双重激动活性的噻唑烷二酮衍生物
MX340013B (es) 2011-03-21 2016-06-22 Hoffmann La Roche Compuestos de benzoxazepina selectivos para fosfatidilinositol 3-cinasa (pi3k) p110 delta y metodos de uso.
NO3175985T3 (ja) * 2011-07-01 2018-04-28
CN104379163A (zh) 2012-06-08 2015-02-25 霍夫曼-拉罗奇有限公司 用于治疗癌症的磷酸肌醇3激酶抑制剂化合物和化疗剂的突变选择性及组合

Similar Documents

Publication Publication Date Title
JP2019089762A5 (ja)
JP2018150298A5 (ja)
JP2018168171A5 (ja)
JP2017008120A5 (ja)
JP2020515557A5 (ja)
JP2018024670A5 (ja)
JP2019194236A5 (ja)
JP2020007340A5 (ja)
JP2020534795A5 (ja)
JP2017186358A5 (ja)
JP2012107057A5 (ja)
JP2017514877A5 (ja)
JP2017137500A5 (ja)
JP2018521020A5 (ja)
JP2019164961A5 (ja)
JP2019124943A5 (ja)
JP2021503553A5 (ja)
JP2018116258A5 (ja)
JP2018186811A5 (ja)
JP2020183924A5 (ja)
JP2021512134A5 (ja)
JP2021129286A5 (ja)
JP2020043052A5 (ja)
JP2011037885A5 (ja)
JP2020049413A5 (ja)